Feed major, ForFarmers, and Remediiate, a company harnessing the potential of microalgae, are joining forces to tackle industrial CO2 emissions and advance sustainability in feed production.
The parties say this alliance, formalized through a letter of intent in the UK, highlights a shared commitment to circular solutions that benefit both the industry and the environment.
At the center of this tie-up is Remediiate’s technology, which is designed to capture CO2 emissions directly from industrial flue stacks.
Using its modular, plug-and-play bioreactor system, the Wales based company accelerates microalgae growth, turning captured carbon into a valuable raw material for various applications.
ForFarmers’ role as a knowledge partner is pivotal to the project’s success. It will leverage its expertise to explore how to make microalgae a practical and sustainable ingredient in animal feed.
Scalable technology
Remediiate’s system can be deployed at any manufacturing site, from power plants and cement factories to chemical producers and food manufacturers.
By utilizing CO2 directly at its source, the technology offers a cost-effective way to reduce industrial greenhouse gas emissions without the need for complex carbon capture and storage solutions.
The innovator maintains that its ability to culture microalgae at scale is transforming a once niche sector into a viable and impactful market. And this alliance will support that transition.
“Our collaboration with ForFarmers is an important step towards sustainable innovation,” says Carlos de Pommes, CEO Remediiate. “With Project LightARC in Wales, we are now capturing CO2 emissions from nickel production to culture microalgae, and in partnership with ForFarmers we are exploring its application in animal feed.”
The partners say they are redefining how industries can collaborate to achieve circularity, ensuring a more sustainable future for farming and beyond.
Power to X project trend
Many other ‘Power-to-X’ projects are emerging, particularly in locations with abundant, and inexpensive renewable energy that can be valorized.
Aerbio, founded in 2024 as a buyout of technology developer, Deep Branch, is advancing its project to transform industrial CO2 and hydrogen into protein-rich ingredients that are also decoupled from sea and only require minimal land. Its Proton product is a feed protein for use in salmon and poultry production.
Located at the renowned Brightlands Chemelot Campus in the Netherlands, a hub for circular chemistry and chemical processes, Aerbio’s pilot facility is fully operational, while engineering efforts are underway for a forthcoming demonstration facility.
“When you look at carbon capture and utilization projects, sourcing high volumes of high-purity CO2, like the food-grade CO2 we use, has become straightforward.
“However, our main cost sensitivity lies in hydrogen, which is the largest contributor to our cost of goods sold,” Aerbio CXO, Peter Rowe, told us in autumn.
One of its four key target markets is aquaculture. “This is our primary focus due to the product’s high protein content, balanced amino acid profile, and other features that make it particularly well-suited for this sector.”
Rowe noted an increasing adoption of single-cell proteins in the human food market, which is also an area of strong interest for the company.
“This market requires consideration of factors like texture, flavor, and mouthfeel, which involve a different application development process compared to animal nutrition. We have secured a strong partner for this, and we’ll be sharing more details soon.”
The innovator is also looking at starter feed application in the monogastric space.
“Similar to aquaculture, this market shares nutritional drivers that align well with our product’s strengths,” he explained.
Pet food is an additional segment that the company has set its sights on, specifically for cat and dog nutrition:
“This market sits between human food and performance animal nutrition, like aquaculture, making it another promising area for exploration. “We aim to eventually have a well-balanced sales portfolio, which includes the ability to tap into and sell to higher-margin markets,” said the CXO.
